Financial News

Rubius Therapeutics, Inc. - Common Stock (NY:ONLN)

51.68 +0.16 (+0.30%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 3,123
Open 51.73
Bid (Size) 50.69 (49)
Ask (Size) 52.74 (47)
Prev. Close 51.52
Today's Range 51.67 - 51.79
52wk Range 36.15 - 51.79
Shares Outstanding 15,200
Dividend Yield 0.28%

Performance

YTD
+14.5%
+14.5%
1 Month
+3.0%
+3.0%
3 Month
+34.7%
+34.7%
6 Month
+13.6%
+13.6%
1 Year
+26.2%
+26.2%

More News

Read More

Frequently Asked Questions

Is Rubius Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rubius Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rubius Therapeutics, Inc. - Common Stock trade on?
Rubius Therapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rubius Therapeutics, Inc. - Common Stock?
The ticker symbol for Rubius Therapeutics, Inc. - Common Stock is ONLN on the New York Stock Exchange
What is the current price of Rubius Therapeutics, Inc. - Common Stock?
The current price of Rubius Therapeutics, Inc. - Common Stock is 51.68
When was Rubius Therapeutics, Inc. - Common Stock last traded?
The last trade of Rubius Therapeutics, Inc. - Common Stock was at 07/03/25 05:00 PM ET
What is the market capitalization of Rubius Therapeutics, Inc. - Common Stock?
The market capitalization of Rubius Therapeutics, Inc. - Common Stock is 785.54K
How many shares of Rubius Therapeutics, Inc. - Common Stock are outstanding?
Rubius Therapeutics, Inc. - Common Stock has 786K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback